---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-113952"
form_type: "8-K"
ticker: "SONX"
cik: "0001407973"
company_name: "Sonendo, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:30:33.304639+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sonendo prelim Q3 rev $7.9-$8.0M, raises FY2024 guidance; stalking horse bid for Biolase assets

## Summary
- Total revenue expected $7.9-$8.0M; console approx $1.8M, procedural instruments approx $5.1M.
- Cash, cash equivalents and short-term investments approx $17.3M at Sept 30, 2024.
- Full-year 2024 revenue guidance raised to $31.5-$32.5M from prior $31.0-$32.0M.
- Double-digit console backlog for third straight quarter.
- Positioned as stalking horse bidder to acquire certain assets of Biolase in Chapter 11 bankruptcy.

## SEC filing metadata
- accession: 0000950170-24-113952
- form_type: 8-K
- ticker: SONX
- cik: 0001407973
- company_name: Sonendo, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/0000950170-24-113952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/sonx-20241010.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-113952
- JSON: https://secwatch.observer/filing/0000950170-24-113952.json
- Plain text: https://secwatch.observer/filing/0000950170-24-113952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.